Granite Point Capital Management, L.P. Celcuity Inc. Transaction History

Granite Point Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$5.35 - $10.11 $930,108 - $1.76 Million	-173,852 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$7.93 - $13.33 $14,274 - $23,994	-1,800 Reduced 1.02%	173,852 $1.63 Million
Q4 2021 Feb 11, 2022	SELL	$11.96 - $19.35 $235,277 - $380,653	-19,672 Reduced 10.07%	175,652 $2.32 Million
Q3 2021 Nov 10, 2021	SELL	$17.35 - $24.87 $1.99 Million - $2.86 Million	-114,874 Reduced 37.03%	195,324 $3.52 Million
Q2 2021 Aug 16, 2021	BUY	$14.25 - $30.93 $1.5 Million - $3.25 Million	105,198 Added 51.32%	310,198 $7.45 Million
Q1 2021 May 12, 2021	BUY	$10.43 - $17.8 $2.14 Million - $3.65 Million	205,000 New	205,000 $2.94 Million

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $208M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.